These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 18271745)

  • 1. Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity.
    Maiden MC; Ibarz-Pavón AB; Urwin R; Gray SJ; Andrews NJ; Clarke SC; Walker AM; Evans MR; Kroll JS; Neal KR; Ala'aldeen DA; Crook DW; Cann K; Harrison S; Cunningham R; Baxter D; Kaczmarski E; Maclennan J; Cameron JC; Stuart JM
    J Infect Dis; 2008 Mar; 197(5):737-43. PubMed ID: 18271745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A decade of herd protection after introduction of meningococcal serogroup C conjugate vaccination.
    Bijlsma MW; Brouwer MC; Spanjaard L; van de Beek D; van der Ende A
    Clin Infect Dis; 2014 Nov; 59(9):1216-21. PubMed ID: 25069869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited Impact of Adolescent Meningococcal ACWY Vaccination on Neisseria meningitidis Serogroup W Carriage in University Students.
    Oldfield NJ; Green LR; Parkhill J; Bayliss CD; Turner DPJ
    J Infect Dis; 2018 Jan; 217(4):608-616. PubMed ID: 29155998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1-4 cross-sectional survey results.
    MacLennan JM; Rodrigues CMC; Bratcher HB; Lekshmi A; Finn A; Oliver J; Wootton M; Ray S; Cameron C; Smith A; Heath PT; Bartolf A; Nolan T; Hughes S; Varghese A; Snape MD; Sewell R; Cunningham R; Stolton A; Kay C; Palmer K; Baxter D; Suggitt D; Zipitis CS; Pemberton N; Jolley KA; Bray JE; Harrison OB; Ladhani SN; Pollard AJ; Borrow R; Gray SJ; Trotter C; Maiden MCJ
    Lancet Infect Dis; 2021 May; 21(5):677-687. PubMed ID: 33482143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine.
    Kristiansen PA; Diomandé F; Wei SC; Ouédraogo R; Sangaré L; Sanou I; Kandolo D; Kaboré P; Clark TA; Ouédraogo AS; Absatou KB; Ouédraogo CD; Hassan-King M; Thomas JD; Hatcher C; Djingarey M; Messonnier N; Préziosi MP; LaForce M; Caugant DA
    Clin Vaccine Immunol; 2011 Mar; 18(3):435-43. PubMed ID: 21228139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Be on the TEAM' Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents.
    Carr J; Plested E; Aley P; Camara S; Davis K; MacLennan JM; Gray S; Faust SN; Borrow R; Christensen H; Trotter C; Maiden MCJ; Finn A; Snape MD;
    BMJ Open; 2020 Oct; 10(10):e037358. PubMed ID: 33093030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation.
    Ibarz-Pavón AB; Maclennan J; Andrews NJ; Gray SJ; Urwin R; Clarke SC; Walker AM; Evans MR; Kroll JS; Neal KR; Ala'aldeen D; Crook DW; Cann K; Harrison S; Cunningham R; Baxter D; Kaczmarski E; McCarthy ND; Jolley KA; Cameron JC; Stuart JM; Maiden MC
    J Infect Dis; 2011 Oct; 204(7):1046-53. PubMed ID: 21881120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac.
    Kristiansen PA; Ba AK; Ouédraogo AS; Sanou I; Ouédraogo R; Sangaré L; Diomandé F; Kandolo D; Saga IM; Misegades L; Clark TA; Préziosi MP; Caugant DA
    BMC Infect Dis; 2014 Dec; 14():663. PubMed ID: 25472422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carriage rate and effects of vaccination after outbreaks of serogroup C meningococcal disease, Brazil, 2010.
    Sáfadi MA; Carvalhanas TR; Paula de Lemos A; Gorla MC; Salgado M; Fukasawa LO; Gonçalves MG; Higa F; Brandileone MC; Sacchi CT; Ribeiro AF; Sato HK; Bricks LF; Cassio de Moraes J
    Emerg Infect Dis; 2014 May; 20(5):806-11. PubMed ID: 24751156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meningococcal carriage 7 years after introduction of a serogroup A meningococcal conjugate vaccine in Burkina Faso: results from four cross-sectional carriage surveys.
    Mbaeyi S; Sampo E; Dinanibè K; Yaméogo I; Congo-Ouédraogo M; Tamboura M; Sawadogo G; Ouattara K; Sanou M; Kiemtoré T; Dioma G; Sanon B; Somlaré H; Kyetega A; Ba AK; Aké F; Tarbangdo F; Aboua FA; Donnou Y; Kamaté I; Patel JC; Schmink S; Spiller MW; Topaz N; Novak R; Wang X; Bicaba B; Sangaré L; Ouédraogo-Traoré R; Kristiansen PA
    Lancet Infect Dis; 2020 Dec; 20(12):1418-1425. PubMed ID: 32653071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal carriage in young adults six years after meningococcal C conjugate (MCC) vaccine catch-up campaign in Salvador, Brazil.
    Ferreira VM; Ferreira ÍE; Chang HY; Nunes AMPB; Topaz N; Pimentel ER; Moura ARSS; Ribeiro GS; Feitosa CA; Reis MG; Wang X; Campos LC
    Vaccine; 2020 Mar; 38(14):2995-3002. PubMed ID: 32115294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and epidemiology of meningococcal carriage in Southern Ethiopia prior to implementation of MenAfriVac, a conjugate vaccine.
    Bårnes GK; Kristiansen PA; Beyene D; Workalemahu B; Fissiha P; Merdekios B; Bohlin J; Préziosi MP; Aseffa A; Caugant DA
    BMC Infect Dis; 2016 Nov; 16(1):639. PubMed ID: 27814682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme.
    Carr JP; MacLennan JM; Plested E; Bratcher HB; Harrison OB; Aley PK; Bray JE; Camara S; Rodrigues CMC; Davis K; Bartolf A; Baxter D; Cameron JC; Cunningham R; Faust SN; Fidler K; Gowda R; Heath PT; Hughes S; Khajuria S; Orr D; Raman M; Smith A; Turner DPJ; Whittaker E; Williams CJ; Zipitis CS; Pollard AJ; Oliver J; Morales-Aza B; Lekshmi A; Clark SA; Borrow R; Christensen H; Trotter C; Finn A; Maiden MC; Snape MD;
    Clin Microbiol Infect; 2022 Dec; 28(12):1649.e1-1649.e8. PubMed ID: 35840033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of meningococcal vaccination with combined serogroups A and C polysaccharide vaccine on carriage of Neisseria meningitidis C.
    Fernández S; Arreaza L; Santiago I; Malvar A; Berrón S; Vazquez JA; Hervada X
    J Med Microbiol; 2003 Jan; 52(Pt 1):75-77. PubMed ID: 12488569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of meningococcal C conjugate vaccine in the UK.
    Balmer P; Borrow R; Miller E
    J Med Microbiol; 2002 Sep; 51(9):717-722. PubMed ID: 12358061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.
    Maiden MC; Stuart JM;
    Lancet; 2002 May; 359(9320):1829-31. PubMed ID: 12044380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity.
    Campbell H; Andrews N; Borrow R; Trotter C; Miller E
    Clin Vaccine Immunol; 2010 May; 17(5):840-7. PubMed ID: 20219881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine.
    Kristiansen PA; Ba AK; Sanou I; Ouédraogo AS; Ouédraogo R; Sangaré L; Diomandé F; Kandolo D; Thomas JD; Clark TA; Laforce M; Caugant DA
    BMC Infect Dis; 2013 Aug; 13():363. PubMed ID: 23914778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carriage rates and risk factors during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C ST-11 (cc11) in Tuscany, Italy: a cross-sectional study.
    Miglietta A; Innocenti F; Pezzotti P; Riccobono E; Moriondo M; Pecile P; Nieddu F; Rossolini GM; Azzari C; ; Balocchini E; Rezza G; Voller F; Stefanelli P
    BMC Infect Dis; 2019 Jan; 19(1):29. PubMed ID: 30621624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meningococcal Carriage among Adolescents after Mass Meningococcal C Conjugate Vaccination Campaigns in Salvador, Brazil.
    Nunes AM; Ribeiro GS; Ferreira ÍE; Moura AR; Felzemburgh RD; de Lemos AP; Reis MG; de Moraes JC; Campos LC
    PLoS One; 2016; 11(11):e0166475. PubMed ID: 27861618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.